Straumann Holding AG (STMN) - Net Assets
Based on the latest financial reports, Straumann Holding AG (STMN) has net assets worth CHF2.06 Billion CHF (≈ $2.61 Billion USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF3.51 Billion ≈ $4.44 Billion USD) and total liabilities (CHF1.45 Billion ≈ $1.83 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Straumann Holding AG liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CHF2.06 Billion |
| % of Total Assets | 58.69% |
| Annual Growth Rate | 11.4% |
| 5-Year Change | 68.92% |
| 10-Year Change | 237.83% |
| Growth Volatility | 18.98 |
Straumann Holding AG - Net Assets Trend (2002–2024)
This chart illustrates how Straumann Holding AG's net assets have evolved over time, based on quarterly financial data. Also explore STMN current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Straumann Holding AG (2002–2024)
The table below shows the annual net assets of Straumann Holding AG from 2002 to 2024. For live valuation and market cap data, see market value of Straumann Holding AG.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CHF2.04 Billion ≈ $2.58 Billion |
+11.16% |
| 2023-12-31 | CHF1.84 Billion ≈ $2.32 Billion |
-0.82% |
| 2022-12-31 | CHF1.85 Billion ≈ $2.34 Billion |
+23.55% |
| 2021-12-31 | CHF1.50 Billion ≈ $1.90 Billion |
+24.01% |
| 2020-12-31 | CHF1.21 Billion ≈ $1.53 Billion |
-11.50% |
| 2019-12-31 | CHF1.37 Billion ≈ $1.73 Billion |
+13.53% |
| 2018-12-31 | CHF1.20 Billion ≈ $1.52 Billion |
+12.56% |
| 2017-12-31 | CHF1.07 Billion ≈ $1.35 Billion |
+68.84% |
| 2016-12-31 | CHF633.68 Million ≈ $801.15 Million |
+4.75% |
| 2015-12-31 | CHF604.97 Million ≈ $764.85 Million |
-17.90% |
| 2014-12-31 | CHF736.84 Million ≈ $931.56 Million |
+16.70% |
| 2013-12-31 | CHF631.38 Million ≈ $798.23 Million |
+0.03% |
| 2012-12-31 | CHF631.21 Million ≈ $798.01 Million |
-5.95% |
| 2011-12-31 | CHF671.12 Million ≈ $848.47 Million |
-3.52% |
| 2010-12-31 | CHF695.63 Million ≈ $879.46 Million |
+9.48% |
| 2009-12-31 | CHF635.42 Million ≈ $803.34 Million |
+18.18% |
| 2008-12-31 | CHF537.66 Million ≈ $679.74 Million |
-13.77% |
| 2007-12-31 | CHF623.50 Million ≈ $788.27 Million |
+23.81% |
| 2006-12-31 | CHF503.57 Million ≈ $636.65 Million |
+19.90% |
| 2005-12-31 | CHF419.99 Million ≈ $530.98 Million |
+34.77% |
| 2004-12-31 | CHF311.63 Million ≈ $393.98 Million |
+21.75% |
| 2003-12-31 | CHF255.97 Million ≈ $323.61 Million |
+34.73% |
| 2002-12-31 | CHF189.98 Million ≈ $240.19 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Straumann Holding AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1542.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CHF2.59 Billion | 126.87% |
| Common Stock | CHF1.59 Million | 0.08% |
| Other Comprehensive Income | CHF-610.66 Million | -29.93% |
| Other Components | CHF60.90 Million | 2.99% |
| Total Equity | CHF2.04 Billion | 100.00% |
Straumann Holding AG Competitors by Market Cap
The table below lists competitors of Straumann Holding AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Eastroc Beverage Group Co Ltd
SHG:605499
|
$15.51 Billion |
|
Lululemon Athletica Inc
F:33L
|
$15.53 Billion |
|
Daqin Railway Co Ltd
SHG:601006
|
$15.54 Billion |
|
Amundi SA
PA:AMUN
|
$15.54 Billion |
|
Entegris Inc
NASDAQ:ENTG
|
$15.47 Billion |
|
Companhia de Saneamento Básico do Estado de São Paulo - SABESP
F:SAJA
|
$15.42 Billion |
|
Jacobs Solutions Inc.
NYSE:J
|
$15.41 Billion |
|
Kimco Realty Corporation
NYSE:KIM
|
$15.38 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Straumann Holding AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,836,179,000 to 2,040,131,000, a change of 203,952,000 (11.1%).
- Net income of 388,316,000 contributed positively to equity growth.
- Dividend payments of 135,428,000 reduced retained earnings.
- Share repurchases of 27,823,000 reduced equity.
- New share issuances of 10,240,000 increased equity.
- Other comprehensive income decreased equity by 31,782,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CHF388.32 Million | +19.03% |
| Dividends Paid | CHF135.43 Million | -6.64% |
| Share Repurchases | CHF27.82 Million | -1.36% |
| Share Issuances | CHF10.24 Million | +0.5% |
| Other Comprehensive Income | CHF-31.78 Million | -1.56% |
| Other Changes | CHF429.00K | +0.02% |
| Total Change | CHF- | 11.11% |
Book Value vs Market Value Analysis
This analysis compares Straumann Holding AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.61x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 69.25x to 6.61x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | CHF1.22 | CHF84.50 | x |
| 2003-12-31 | CHF1.64 | CHF84.50 | x |
| 2004-12-31 | CHF1.99 | CHF84.50 | x |
| 2005-12-31 | CHF2.68 | CHF84.50 | x |
| 2006-12-31 | CHF3.22 | CHF84.50 | x |
| 2007-12-31 | CHF3.97 | CHF84.50 | x |
| 2008-12-31 | CHF3.45 | CHF84.50 | x |
| 2009-12-31 | CHF4.07 | CHF84.50 | x |
| 2010-12-31 | CHF4.44 | CHF84.50 | x |
| 2011-12-31 | CHF4.30 | CHF84.50 | x |
| 2012-12-31 | CHF4.08 | CHF84.50 | x |
| 2013-12-31 | CHF4.06 | CHF84.50 | x |
| 2014-12-31 | CHF4.68 | CHF84.50 | x |
| 2015-12-31 | CHF3.82 | CHF84.50 | x |
| 2016-12-31 | CHF4.03 | CHF84.50 | x |
| 2017-12-31 | CHF6.87 | CHF84.50 | x |
| 2018-12-31 | CHF7.56 | CHF84.50 | x |
| 2019-12-31 | CHF8.57 | CHF84.50 | x |
| 2020-12-31 | CHF7.57 | CHF84.50 | x |
| 2021-12-31 | CHF9.37 | CHF84.50 | x |
| 2022-12-31 | CHF11.60 | CHF84.50 | x |
| 2023-12-31 | CHF11.52 | CHF84.50 | x |
| 2024-12-31 | CHF12.79 | CHF84.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Straumann Holding AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 19.03%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.51%
- • Asset Turnover: 0.69x
- • Equity Multiplier: 1.77x
- Recent ROE (19.03%) is below the historical average (21.15%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 29.63% | 20.36% | 1.10x | 1.33x | CHF37.08 Million |
| 2003 | 31.60% | 23.35% | 0.98x | 1.38x | CHF54.89 Million |
| 2004 | 32.29% | 23.78% | 1.04x | 1.31x | CHF69.00 Million |
| 2005 | 30.55% | 25.09% | 0.95x | 1.28x | CHF86.02 Million |
| 2006 | 28.14% | 23.65% | 0.93x | 1.28x | CHF91.37 Million |
| 2007 | 28.38% | 24.64% | 0.75x | 1.53x | CHF113.90 Million |
| 2008 | 1.52% | 1.05% | 1.07x | 1.35x | CHF-45.60 Million |
| 2009 | 23.04% | 19.88% | 0.92x | 1.26x | CHF82.83 Million |
| 2010 | 18.84% | 17.77% | 0.86x | 1.23x | CHF61.52 Million |
| 2011 | 10.57% | 10.23% | 0.85x | 1.21x | CHF3.84 Million |
| 2012 | 5.77% | 5.31% | 0.89x | 1.22x | CHF-26.68 Million |
| 2013 | 16.03% | 14.88% | 0.67x | 1.62x | CHF38.06 Million |
| 2014 | 21.42% | 22.22% | 0.61x | 1.58x | CHF84.14 Million |
| 2015 | 11.68% | 8.85% | 0.76x | 1.73x | CHF10.18 Million |
| 2016 | 36.23% | 25.02% | 0.84x | 1.72x | CHF166.23 Million |
| 2017 | 25.50% | 24.54% | 0.66x | 1.57x | CHF165.91 Million |
| 2018 | 22.71% | 20.00% | 0.73x | 1.55x | CHF152.68 Million |
| 2019 | 22.48% | 19.20% | 0.67x | 1.75x | CHF170.13 Million |
| 2020 | 7.58% | 6.40% | 0.56x | 2.12x | CHF-29.19 Million |
| 2021 | 26.49% | 19.59% | 0.68x | 1.98x | CHF246.54 Million |
| 2022 | 23.48% | 18.73% | 0.69x | 1.82x | CHF249.63 Million |
| 2023 | 13.40% | 10.20% | 0.73x | 1.81x | CHF62.45 Million |
| 2024 | 19.03% | 15.51% | 0.69x | 1.77x | CHF184.30 Million |
Industry Comparison
This section compares Straumann Holding AG's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $3,718,656,465
- Average return on equity (ROE) among peers: 8.47%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Straumann Holding AG (STMN) | CHF2.06 Billion | 29.63% | 0.70x | $15.48 Billion |
| Alcon AG (ALC) | $21.55 Billion | 4.72% | 0.41x | $30.03 Billion |
| Coltene Holding AG (CLTN) | $90.23 Million | 9.12% | 1.08x | $292.50 Million |
| SKAN Group AG (SKAN) | $86.87 Million | 5.15% | 0.02x | $1.13 Billion |
| Tecan Group AG (TECN) | $143.33 Million | 9.74% | 1.36x | $1.72 Billion |
| IVF Hartmann Holding AG (VBSN) | $48.48 Million | 21.37% | 0.47x | $336.00 Million |
| Ypsomed Holding AG (YPSN) | $390.03 Million | 0.70% | 0.60x | $3.85 Billion |
About Straumann Holding AG
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company also offers dental implants and components made f… Read more